ROLE OF ANTIPROGESTERONE ON THE ENDOMETRIUM RECEPTIVITY- A REVIEW

Antiprogesterone on Endometrium Receptivity

Authors

  • Khadija Qamar Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Rubina Mushtaq Combined Military Hospital Rawalpindi Pakistan
  • Humaira Arshad Combined Military Hospital Quetta Pakistan

Keywords:

Antiprogestins, Endometrial changes, Uterine bleeding

Abstract

Estrogen produces proliferation in the functional layer of the endometrium and the differentiation in theciliated and secretory epithelium of the uterine tube. Progesterone produces differentiation in the functional layer of the endometrium and the produces mitosis in the stroma of the endometrium. These effects of the estrogen and progesterone are mediated through interactions with specific intracellular receptors1. Mifepristone (RU 486) is a steroid hormone with a chemical structure similar to natural hormone progesterone. It has been proposed that antiprogestins may be useful in the treatment of endometrial inflammatory disease and carcinoma +breast because these conditions are dependent on the ovarian receptors and have receptors for estrogen and progesterone. Anti-progesterone compounds can antagonize the biological action of the progesterone or inhibit the synthesis of progesterone. Mifepristone, (RU 486) has been found to be the most effective and is now used in practice.

 

Keywords : , , .

 

Downloads

Download data is not yet available.

Downloads

Published

30-04-2016

Issue

Section

Review Articles

How to Cite

1.
Qamar K, Mushtaq R, Arshad H. ROLE OF ANTIPROGESTERONE ON THE ENDOMETRIUM RECEPTIVITY- A REVIEW: Antiprogesterone on Endometrium Receptivity. Pak Armed Forces Med J [Internet]. 2016 Apr. 30 [cited 2024 Dec. 30];66(2):290-93. Available from: https://pafmj.org/PAFMJ/article/view/593